Physician
Retina Consultants, PA, II
Retina Consultants, PA, II was paid $998K by Medicaid between Jan 2018 and Nov 2024, across 46 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 32% of everything it billed.
33Billing provider infoRETINA CONSULTANTS, PA, II
RIDGEWOOD, NJ 07450
RIDGEWOOD, NJ 07450
33aNPI1215906169assigned 03/14/2006
33bProvider typeOphthalmology Physician
28Total paid$998K
24GClaims74,180
24DCodes billed46
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Ophthalmology Physician providers in New Jersey
Rank by total paid#18 of 213
Median peer was paid$20K
This provider vs. median51×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,824 | $135K | |
| 2019 | 12,065 | $140K | |
| 2020 | 6,807 | $109K | |
| 2021 | 8,648 | $150K | |
| 2022 | 12,424 | $200K | |
| 2023 | 10,850 | $164K | |
| 2024incomplete | 9,562 | $99K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 32% | 587 | 340 | $320K |
| 92134 | 17% | 16,191 | 14,310 | $171K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 17% | 5,248 | 4,372 | $171K |
| J9035 | Injection, bevacizumab, 10 mg | 7.8% | 2,173 | 1,889 | $78K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 5.9% | 1,916 | 1,776 | $59K |
| 92226 | 5.2% | 4,691 | 2,685 | $51K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.2% | 1,734 | 1,608 | $42K |
| 92201 | 3.5% | 5,821 | 5,151 | $34K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 2.0% | 890 | 819 | $20K |
| 92225 | 1.6% | 827 | 435 | $15K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 291 | 269 | $15K |
| 92250 | <1% | 256 | 254 | $7K |
34 more codes
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 52 | $6K |
| 92235 | <1% | 92 | $4K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 137 | $2K |
| 76512 | <1% | 35 | $1K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 13 | $503.10 |
| J7999 | Compounded drug, not otherwise classified | <1% | 17 | $335.00 |
| 92202 | <1% | 59 | $260.80 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 1,795 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 1,315 | $0.00 |
| 4040F | 0% | 3,615 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 4,680 | $0.00 |
| 2026F | 0% | 1,404 | $0.00 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 3,028 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 1,629 | $0.00 |
| 5010F | 0% | 352 | $0.00 | |
| 2021F | 0% | 388 | $0.00 | |
| 2022F | 0% | 1,476 | $0.00 | |
| 2024F | 0% | 1,418 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 692 | $0.00 |
| G2104 | Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewed | 0% | 26 | $0.00 |
| G9974 | Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity | 0% | 15 | $0.00 |
| G2102 | Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed | 0% | 26 | $0.00 |
| 1036F | 0% | 4,031 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 2,239 | $0.00 |
| G8952 | Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given | 0% | 294 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 3,484 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 668 | $0.00 |
| 4177F | 0% | 27 | $0.00 | |
| G8397 | Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy | 0% | 354 | $0.00 |
| 2023F | 0% | 42 | $0.00 | |
| G8428 | Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given | 0% | 60 | $0.00 |
| 3072F | 0% | 55 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 12 | $0.00 |
| G2103 | Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewed | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKAYSERMAN, LARISA (PRESIDENT)